Currently, there are 864.00M common shares owned by the public and among those 710.05M shares have been available to trade.
The company’s stock has a 5-day price change of 21.38% and 15.19% over the past three months. WBA shares are trading -60.21% year to date (YTD), with the 12-month market performance down to -57.82% lower. It has a 12-month low price of $8.08 and touched a high of $27.05 over the same period. WBA has an average intraday trading volume of 23.31 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 15.81%, 12.20%, and -21.14% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Walgreens Boots Alliance Inc (NASDAQ: WBA) shares accounts for 60.96% of the company’s 864.00M shares outstanding.
It has a market capitalization of $9.59B and a beta (3y monthly) value of 0.63. The earnings-per-share (ttm) stands at -$10.01. Price movements for the stock have been influenced by the stock’s volatility, which stands at 12.65% over the week and 6.36% over the month.
Earnings per share for the fiscal year are expected to decrease by -46.81%, and -4.89% over the next financial year.
Looking at the support for the WBA, a number of firms have released research notes about the stock. Leerink Partners stated their Market Perform rating for the stock in a research note on February 26, 2024, with the firm’s price target at $23. Barclays was of a view on January 03, 2024 that the stock is Underweight, while HSBC Securities gave the stock Hold rating on December 22, 2023, issuing a price target of $27. JP Morgan on their part issued Overweight rating on October 23, 2023.
